Parexel International Corporation

Parexel International Corporation is a leading global biopharmaceutical services organization specializing in providing comprehensive clinical research and consulting solutions to the pharmaceutical, biotechnology, and medical device industries. Established in 1982, Parexel has grown to become one of the world's largest contract research organizations (CROs). It employs approximately 21,000 professionals operating across more than 84 facilities in over 51 countries.

The company's primary focus is to expedite the development of new therapies by offering a broad spectrum of services that cover the entire clinical development process. These services include clinical trial management, data management, medical writing, biostatistics, pharmacovigilance, regulatory consulting, and medical communications.

By leveraging its deep local knowledge and global expertise, Parexel partners with biopharmaceutical leaders, emerging innovators, and clinical sites to design and deliver clinical trials that prioritize patient-centric approaches.

Innovation and Recognition

In recent years, Parexel has been at the forefront of integrating innovative technologies into clinical research. In 2024, the company established a collaboration with Palantir Technologies to enhance its clinical study design and capacity by utilizing artificial intelligence for data management solutions in clinical trials.

Parexel has also been recognized for its commitment to diversity and workplace culture. It earned the 2022 India Workplace Equality Index (IWEI)’s Top Employers Award for the third consecutive year and the 2022-2023 Mercer China Healthiest Workplace Awards for Outstanding Health Practice Award.

Locations and Expansion

Parexel's global presence includes significant operations in North Carolina, with a second U.S. headquarters in Durham County. This expansion, announced in 2019, added 264 jobs and underscored the company's commitment to the region's life sciences sector.

In India, Parexel operates between 100 and 150 trial sites across various states. These include:

• Maharashtra
• Karnataka
• Telangana
• Tamil Nadu

The company plans to increase its workforce in India by over 2,000 employees within the next three to five years, reflecting its strategic focus on the Asia/Pacific region.

Additionally, Parexel maintains its headquarters in Norristown, PA, USA, serving as an important hub for its operations.

Global Impact

Through its extensive global network and dedication to innovation, Parexel International Corporation continues to play a pivotal role in advancing clinical research and bringing life-changing treatments to patients worldwide.